About
Endogastric Solutions develops and provides the EsophyX® Z+ device and TIF 2.0® procedure, a minimally invasive endoscopic treatment for gastroesophageal reflux disease (GERD) that reconstructs the gastroesophageal flap valve without external incisions.
Explore Endogastric Solutions's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.